Shunsuke Misono

457 total citations
17 papers, 341 citations indexed

About

Shunsuke Misono is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shunsuke Misono has authored 17 papers receiving a total of 341 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 11 papers in Cancer Research and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shunsuke Misono's work include MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (9 papers). Shunsuke Misono is often cited by papers focused on MicroRNA in disease regulation (11 papers), RNA modifications and cancer (10 papers) and Cancer-related molecular mechanisms research (9 papers). Shunsuke Misono collaborates with scholars based in Japan. Shunsuke Misono's co-authors include Hiromasa Inoue, Naohiko Seki, Akifumi Uchida, Keiko Mizuno, Takayuki Suetsugu, Tomohiro Kumamoto, Yasutaka Yamada, Naoko Kikkawa, Shogo Moriya and Takayuki Arai and has published in prestigious journals such as International Journal of Molecular Sciences, Cells and Cellular Signalling.

In The Last Decade

Shunsuke Misono

16 papers receiving 337 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shunsuke Misono Japan	11	271	213	68	48	23	17	341
Pei-Cong Shi China	6	228 0.8×	146 0.7×	37 0.5×	57 1.2×	21 0.9×	6	288
Nanhang Lu China	7	263 1.0×	151 0.7×	48 0.7×	86 1.8×	39 1.7×	16	357
Weijian Guo China	6	214 0.8×	157 0.7×	73 1.1×	85 1.8×	24 1.0×	9	305
Yuandong Feng China	11	291 1.1×	210 1.0×	32 0.5×	69 1.4×	32 1.4×	23	362
Hsuan-Yu Peng Taiwan	9	285 1.1×	219 1.0×	29 0.4×	72 1.5×	29 1.3×	10	368
Yugang Ge China	11	256 0.9×	207 1.0×	44 0.6×	53 1.1×	12 0.5×	17	330
Gloria Ros Italy	9	314 1.2×	219 1.0×	32 0.5×	75 1.6×	20 0.9×	13	378
Shuhang Qin China	9	181 0.7×	148 0.7×	58 0.9×	63 1.3×	38 1.7×	12	298
Yaqi Gan China	9	280 1.0×	173 0.8×	80 1.2×	61 1.3×	27 1.2×	10	360

Countries citing papers authored by Shunsuke Misono

Since Specialization

Citations

This map shows the geographic impact of Shunsuke Misono's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shunsuke Misono with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shunsuke Misono more than expected).

Fields of papers citing papers by Shunsuke Misono

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shunsuke Misono. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shunsuke Misono. The network helps show where Shunsuke Misono may publish in the future.

Co-authorship network of co-authors of Shunsuke Misono

This figure shows the co-authorship network connecting the top 25 collaborators of Shunsuke Misono. A scholar is included among the top collaborators of Shunsuke Misono based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shunsuke Misono. Shunsuke Misono is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Saruwatari, Koichi, Takaaki Tokito, Yoshihiko Sakata, et al.. (2025). Impact of durvalumab re-administration after moderate symptomatic pneumonitis in locally advanced non-small cell lung cancer. Lung Cancer. 204. 108578–108578.

Saruwatari, Koichi, Kenta Murotani, Takaaki Tokito, et al.. (2024). Real-World Efficacy and Safety of Durvalumab Administration Following Chemoradiotherapy in Elderly Patients With Unresectable Locally Advanced Nonsmall Cell Lung Cancer: A Multicenter, Retrospective Study. Clinical Lung Cancer. 25(8). 661–671.e7. 2 indexed citations

Misono, Shunsuke, Naoko Kikkawa, Takayuki Suetsugu, et al.. (2023). Minichromosome maintenance proteins in lung adenocarcinoma: Clinical significance and therapeutic targets. FEBS Open Bio. 13(9). 1737–1755. 5 indexed citations

Suetsugu, Takayuki, Shunsuke Misono, Yusuke Goto, et al.. (2023). Identification of Tumor-Suppressive miR-139-3p-Regulated Genes: TRIP13 as a Therapeutic Target in Lung Adenocarcinoma. Cancers. 15(23). 5571–5571. 7 indexed citations

Misono, Shunsuke, Keiko Mizuno, Takayuki Suetsugu, et al.. (2022). MicroRNA signature of small‐cell lung cancer after treatment failure: impact on oncogenic targets by miR‐30a‐3p control. Molecular Oncology. 17(2). 328–343. 7 indexed citations

Mizuno, Keiko, Shunsuke Misono, Takayuki Suetsugu, et al.. (2021). Regulation of Oncogenic Targets by Tumor-Suppressive miR-150-3p in Lung Squamous Cell Carcinoma. Biomedicines. 9(12). 1883–1883. 10 indexed citations

Misono, Shunsuke, Keiko Mizuno, Takayuki Suetsugu, et al.. (2021). Molecular Signature of Small Cell Lung Cancer after Treatment Failure: The MCM Complex as Therapeutic Target. Cancers. 13(6). 1187–1187. 12 indexed citations

Mizuno, Keiko, Nijiro Nohata, Shunsuke Misono, et al.. (2020). FAM64A: A Novel Oncogenic Target of Lung Adenocarcinoma Regulated by Both Strands of miR-99a (miR-99a-5p and miR-99a-3p). Cells. 9(9). 2083–2083. 20 indexed citations

Misono, Shunsuke, Naohiko Seki, Keiko Mizuno, et al.. (2019). Molecular Pathogenesis of Gene Regulation by the miR-150 Duplex: miR-150-3p Regulates TNS4 in Lung Adenocarcinoma. Cancers. 11(5). 601–601. 37 indexed citations

10.

Uchida, Akifumi, Naohiko Seki, Keiko Mizuno, et al.. (2019). Regulation of KIF2A by Antitumor miR-451a Inhibits Cancer Cell Aggressiveness Features in Lung Squamous Cell Carcinoma. Cancers. 11(2). 258–258. 28 indexed citations

11.

Mizuno, Keiko, et al.. (2019). Effect of bevacizumab on brain radiation necrosis in anaplastic lymphoma kinase‐positive lung cancer. Respirology Case Reports. 7(7). e00454–e00454. 9 indexed citations

12.

Seki, Naohiko, Keiko Mizuno, Shunsuke Misono, et al.. (2019). Involvement of Dual Strands of miR-143 (miR-143-5p and miR-143-3p) and Their Target Oncogenes in the Molecular Pathogenesis of Lung Adenocarcinoma. International Journal of Molecular Sciences. 20(18). 4482–4482. 53 indexed citations

13.

Yamada, Yasutaka, Mayuko Kato, Takayuki Arai, et al.. (2019). Aberrantly expressed PLOD1 promotes cancer aggressiveness in bladder cancer: a potential prognostic marker and therapeutic target. Molecular Oncology. 13(9). 1898–1912. 32 indexed citations

14.

Misono, Shunsuke, Naohiko Seki, Keiko Mizuno, et al.. (2018). Dual strands of the miR-145 duplex (miR-145-5p and miR-145-3p) regulate oncogenes in lung adenocarcinoma pathogenesis. Journal of Human Genetics. 63(10). 1015–1028. 30 indexed citations

15.

Uchida, Akifumi, Naohiko Seki, Keiko Mizuno, et al.. (2018). Involvement of dual‐strand of the miR‐144 duplex and their targets in the pathogenesis of lung squamous cell carcinoma. Cancer Science. 110(1). 420–432. 30 indexed citations

16.

Takagi, Koichi, Munekazu Yamakuchi, Takahiro Matsuyama, et al.. (2017). IL-13 enhances mesenchymal transition of pulmonary artery endothelial cells via down-regulation of miR-424/503 in vitro. Cellular Signalling. 42. 270–280. 27 indexed citations

17.

Suetsugu, Takayuki, Keiichi Koshizuka, Naohiko Seki, et al.. (2017). Downregulation of matrix metalloproteinase 14 by the antitumor miRNA, miR-150-5p, inhibits the aggressiveness of lung squamous cell carcinoma cells. International Journal of Oncology. 52(3). 913–924. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact